"Caspase Inhibitors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Endogenous and exogenous compounds and that either inhibit CASPASES or prevent their activation.
| Descriptor ID |
D061945
|
| MeSH Number(s) |
D27.505.519.389.745.325.500
|
| Concept/Terms |
Caspase Activation Inhibitors- Caspase Activation Inhibitors
- Activation Inhibitors, Caspase
- Inhibitors, Caspase Activation
- Caspase Activation Blockers
- Activation Blockers, Caspase
- Blockers, Caspase Activation
- Capase Activation Inhibitors
- Activation Inhibitors, Capase
- Inhibitors, Capase Activation
|
Below are MeSH descriptors whose meaning is more general than "Caspase Inhibitors".
Below are MeSH descriptors whose meaning is more specific than "Caspase Inhibitors".
This graph shows the total number of publications written about "Caspase Inhibitors" by people in this website by year, and whether "Caspase Inhibitors" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 0 | 2 | 2 |
| 1999 | 1 | 2 | 3 |
| 2001 | 0 | 2 | 2 |
| 2002 | 0 | 1 | 1 |
| 2003 | 1 | 1 | 2 |
| 2004 | 0 | 3 | 3 |
| 2005 | 1 | 3 | 4 |
| 2008 | 0 | 1 | 1 |
| 2010 | 0 | 1 | 1 |
| 2014 | 0 | 3 | 3 |
| 2016 | 0 | 1 | 1 |
| 2017 | 0 | 1 | 1 |
| 2018 | 1 | 0 | 1 |
| 2022 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Caspase Inhibitors" by people in Profiles.
-
Blebbishields, the emergency program for cancer stem cells: sphere formation and tumorigenesis after apoptosis. Cell Death Differ. 2013 Mar; 20(3):382-95.
-
Direct cytotoxicity produced by adenoviral-mediated interferon a gene transfer in interferon-resistant cancer cells involves ER stress and caspase 4 activation. Cancer Gene Ther. 2011 Sep; 18(9):609-16.
-
Convergent transcription through a long CAG tract destabilizes repeats and induces apoptosis. Mol Cell Biol. 2010 Sep; 30(18):4435-51.
-
Tumor suppressor 101F6 and ascorbate synergistically and selectively inhibit non-small cell lung cancer growth by caspase-independent apoptosis and autophagy. Cancer Res. 2007 Jul 01; 67(13):6293-303.
-
Gefitinib reverses TRAIL resistance in human bladder cancer cell lines via inhibition of AKT-mediated X-linked inhibitor of apoptosis protein expression. Cancer Res. 2007 Feb 15; 67(4):1430-5.
-
Activity of AMN107, a novel aminopyrimidine tyrosine kinase inhibitor, against human FIP1L1-PDGFR-alpha-expressing cells. Leuk Res. 2006 Dec; 30(12):1499-505.
-
Maspin overexpression modulates tumor cell apoptosis through the regulation of Bcl-2 family proteins. BMC Cancer. 2005 May 20; 5:50.
-
Prostaglandin D2 induces programmed cell death in Trypanosoma brucei bloodstream form. Cell Death Differ. 2005 Apr; 12(4):335-46.
-
ATR and GADD45alpha mediate HIV-1 Vpr-induced apoptosis. Cell Death Differ. 2005 Apr; 12(4):326-34.
-
Sequence-based discovery of a synthetic peptide inhibitor of caspase 6. Apoptosis. 2003 Aug; 8(4):371-6.